OpenCell Technologies provides efficient, high-throughput and scalable transfection tools to researchers in the Life Sciences, enabling them to use difficult-to-transfect cells (e.g., primary and cancer stem cell cultures) in development of cell-based analysis techniques and discovery of new cancer therapies. Unlike currently available products, the OpenCell technology features precise control of biophysical actions on a single-cell basis without sacrificing throughput. OpenCells vision is to realize a novel, cost-effective approach to transfection that overcome existing research and development obstacles.
-
Number of Employees:
0-25
-
Annual Revenue:
$1-10 Million